Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function

Journal: Molecular Cell

Published: 2018-01-18

DOI: 10.1016/j.molcel.2017.12.024

Affiliations: 15

Authors: 20

Go to article
Institutions FC
Department of Molecular Medicine / Institute of Biotechnology (IBT), UT Health San Antonio, United States of America (USA) 0.17
Department of Pathology, BIDMC, United States of America (USA) 0.17
Mackay Memorial Hospital (MMH), Taiwan 0.15
Department of Molecular and Cellular Oncology, MD Anderson Cancer Center, United States of America (USA) 0.10
Department of Pathology, MD Anderson Cancer Center, United States of America (USA) 0.10
Department of Molecular Oncology, MOFFITT, United States of America (USA) 0.08
Cell Signaling Technology, Inc., United States of America (USA) 0.05
Department of Medicine, BIDMC, United States of America (USA) 0.05
Chinese National Human Genome Center - Shanghai (CHGC), China 0.03
Graduate Institute of Biomedical Sciences, CMU, Taiwan 0.03
Center for Molecular Medicine, CMU, Taiwan 0.03
Department of Medical Oncology, DFCI, United States of America (USA) 0.02
Center for Functional Cancer Epigenetics (CFCE), DFCI, United States of America (USA) 0.02
Cancer Center at Wuhan Union Hospital, HUST, China 0.02
Department of Obstetrics and Gynecology, HUST, China 0.02

Return